Sign In

Ann Macdonald

Senior Business Development Manager -Cell and Gene Therapy at Thermo Fisher Scientific

Ann Macdonald is an experienced commercial scientist who currently holds the position of Senior Business Development Manager for Cell and Gene Therapy at Thermo Fisher Scientific.24 With over 25 years of experience supporting customers in the scientific industry, she brings a wealth of knowledge to her role.2

Based in Paisley, Scotland, United Kingdom, Ann Macdonald focuses on aiding customers in the cell and gene therapy sector.4 Her expertise likely involves helping clients with solutions for gene therapy analysis, production, and characterization, which are key areas of focus for Thermo Fisher Scientific in this field.1

Ann Macdonald is active in industry events and knowledge sharing. For example, she has presented on topics such as scaling and automating end-to-end cell therapy manufacturing workflows at showcase events.5 This suggests she has a deep understanding of the practical challenges and solutions in cell and gene therapy manufacturing processes.

Her LinkedIn profile can be found under the username ann-macdonald-63ba5b3, where she likely shares insights and updates related to her work in the cell and gene therapy industry.3

Highlights

Aug 28 · linkedin

🌟New webinar alert🌟 Register now for our upcoming webinar titled, "From the Lab to the Bench: Scaling up Regulatory T Cell Therapy."   Register here: https://lnkd.in/gbYgfq5e   🗓️ Date: Thursday, September 12th, 2024 🕗 Time: 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST   Regulatory T cells (Tregs) play a critical role in maintaining immune balance and preventing autoimmune diseases. Join us to explore the potential of Treg expansion as a promising therapeutic approach.   Our webinar will talk about a novel technology that provides an optimized activation signal for Treg expansion, ensuring a high-fold increase in suppressive Tregs with a stable FOXP3 phenotype and more!  

  1. Learn how a relevant number of regulatory T cells is achieved with >800-fold expansion after two stimulations
  2. Hear how Tregs can be activated and expanded in a closed, automated system
  3. How CAR-engineered Tregs can induce immune tolerance   Don't miss out on this opportunity! #Webinar #RegulatoryTCellTherapy #Immunology #Autoimmune
Aug 21 · linkedin

Join our upcoming online event 💻, "Optimising Cell Therapy Manufacturing" on 17th September at 1pm CEST and 12pm BST. Don't miss this chance to gain valuable insights from industry experts. Register now through the link below.   Get ready for an engaging virtual event featuring Hololens demos, where industry experts will share insights and solutions to enhance efficiency in cell therapy manufacturing.    This webinar will cover a range of topics including leveraging advanced systems for T cell engineering, challenges and solutions in GMP manufacturing of cell therapies, development of off-the-shelf cell therapies, and streamlining manufacturing processes.    Don't miss this opportunity to discover strategies to optimize your cell therapy manufacturing workflows.   Link to register:  https://lnkd.in/etwWkn4M

Related Questions

What are Ann Macdonald's main responsibilities at Thermo Fisher Scientific?
How has Ann Macdonald contributed to the field of cell and gene therapy?
What specific products or technologies does Ann Macdonald focus on?
Can you provide examples of Ann Macdonald's work in gene therapy?
What is Ann Macdonald's educational background?
A
Add to my network

Location

Paisley, Scotland, United Kingdom